← Back to RPRX

Royalty Pharma plc - Class A Ordinary Shares financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 05/08/2026Mar 2026Filed 06/05/2026Sep 2025Filed 05/11/2025Jun 2025Filed 05/08/2026Mar 2025Filed 06/05/2026Sep 2024Filed 05/11/2025Jun 2024Filed 06/08/2025Mar 2024Filed 08/05/2025
$674$631$609$579$568$565$537$568
$18$295$288$32$239$544$102$4.8
$0.04$0.67$0.67$0.07$0.55$1.21$0.23$0.01
557557560562578593597597

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.